• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jonathan Avery Explains How Substance Use Affects the Care of Patients With Mental Illness

Video

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, discussed how some psychiatrists will back away when treating a patient with co-occurring substance use and mental illness, when instead they should be leaning in to deliver evidence-based treatment.

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, discussed how some psychiatrists will back away when treating a patient with co-occurring substance use and mental illness, when instead they should be leaning in to deliver evidence-based treatment.

Transcript

How do concurrent substance use disorders affect how psychiatrists treat patients with mental illnesses?

Our hope is that co-occurring disorders cause a psychiatrist to lean in and offer all the evidence-based treatments. I think in practice what happens is that we tend to back out of the room when it looks like a complicated patient has multiple diagnoses, especially substance use disorders, and I think we tend to undertreat or refer out and not treat ourselves. And part of that is stigma-related, I think it’s been shown repeatedly that doctors have worse attitudes towards patients with co-occurring disorders than towards more simple cases. We really want them to not do non—evidence-based things, to not sort of back away but really to offer all the evidence-based treatments for the different diagnoses that they have.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
ISPOR 2024 Recap
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.